Zealand Pharma Completes Enrollment in EASE-SBS 1 Phase 3 Trial Assessing Glepaglutide in Patients with Short Bowel Syndrome

https://www.globenewswire.com/news-release/2022/01/20/2370046/0/en/Zealand-Pharma-Completes-Enrollment-in-EASE-SBS-1-Phase-3-Trial-Assessing-Glepaglutide-in-Patients-with-Short-Bowel-Syndrome.html

press release